ROBERT DOAN: Open Payments
NPI 1063516300 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 28 payments from 9 companies in 2025. Trend: 2023 $401 · 2024 $635 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $269 |
| AstraZeneca Pharmaceuticals LP | 10 | $179 |
| ABBVIE INC. | 1 | $95 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Ozempic, UBRELVY, AIRSUPRA, Sunosi, FARXIGA, Wegovy, BREZTRI, NEFFY.
Industry payments across TX — which companies pay providers there.
